Ranibizumab for diabetic macular edema: Results from 2 phase iii randomized trials: RISE and RIDE

Ophthalmology

Volumn 119, Issue 4, 2012, Pages 789-801

  Nguyen, Quan Dong ^a   Brown, David M ^b   Marcus, Dennis M ^c   Boyer, David S ^d   Patel, Sunil ^e   Feiner, Leonard ^f   Gibson, Andrea ^g   Sy, Judy ^g   Rundle, Amy Chen ^g   Hopkins, J Jill ^g   Rubio, Roman G ^g   Ehrlich, Jason S ^g  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c Southeast Retina Center   (United States)

^d RETINA VITREOUS ASSOCIATES MEDICAL GROUP   (United States)

^e West Texas Retina   (United States)

^f Retina Associates of New Jersey   (United States)

^g GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB; VASCULOTROPIN;

ABRASION; ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ARTERY OCCLUSION; ARTICLE; BRAIN ISCHEMIA; CAPSULE OPACIFICATION; CATARACT; CEREBROVASCULAR ACCIDENT; CLINICAL PROTOCOL; CLOSED ANGLE GLAUCOMA; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORNEA OPACITY; DEATH; DIABETIC MACULAR EDEMA; DIABETIC NEPHROPATHY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG SCREENING; DUODENAL ULCER BLEEDING; ENDOPHTHALMITIS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HEMATURIA; HEMORRHAGIC COLITIS; HUMAN; HYPERTENSION; INCIDENCE; INTESTINE PERFORATION; INTRAOCULAR PRESSURE; LACUNAR STROKE; LASER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEPHROTIC SYNDROME; OPTICAL COHERENCE TOMOGRAPHY; PEPTIC ULCER BLEEDING; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECTUM HEMORRHAGE; RETINA DETACHMENT; RETINA HEMORRHAGE; RETINA TEAR; RETROPERITONEAL HEMORRHAGE; SIDE EFFECT; SINGLE DRUG DOSE; STRATIFIED SAMPLE; SUBRETINAL NEOVASCULARIZATION; TRANSIENT ISCHEMIC ATTACK; TRAUMATIC CATARACT; UVEITIS; VISUAL ACUITY; VISUAL IMPAIRMENT; VITREOUS HEMORRHAGE;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; DIABETIC RETINOPATHY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; LASER COAGULATION; MACULAR EDEMA; MALE; MIDDLE AGED; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84863401792     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2011.12.039     Document Type: Article

References (32)

1. D.S. Fong, L.P. Aiello, F.L. Ferris III, R. Klein Diabetic retinopathy Diabetes Care 27 2004 2540 2553 (Pubitemid 39281419)
2. Centers for Disease Control and Prevention National Diabetes Fact Sheet, 2011 2011 U.S. Department of Health and Human Services, Centers for Disease Control and Prevention Atlanta 8 http://www.cdc.gov/diabetes/pubs/pdf/ndfs-2011. pdf Accessed April 20, 2011
3. X. Zhang, J.B. Saaddine, C.F. Chou Prevalence of diabetic retinopathy in the United States, 20052008 JAMA 304 2010 649 656
4. M.W. Johnson Etiology and treatment of macular edema Am J Ophthalmol 147 2009 11 21
5. R. Klein, B.E. Klein, S.E. Moss The Wisconsin Epidemiologic Study of Diabetic Retinopathy IV. Diabetic macular edema Ophthalmology 91 1984 1464 1474 (Pubitemid 15197017)
6. International Diabetes Federation IDF Diabetes Atlas 4th ed. 2009 IDF Executive Office Brussels, Belgium http://www.diabetesatlas.org/ Accessed April 20, 2011
7. J.C. Javitt, L.P. Aiello, Y. Chiang Preventive eye care in people with diabetes is cost-saving to the federal government: implications for health-care reform Diabetes Care 17 1994 909 917 (Pubitemid 24235519)
8. Early Treatment Diabetic Retinopathy Study Research Group Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1 Arch Ophthalmol 103 1985 1796 1806
9. P. Mitchell, F. Bandello, U. Schmidt-Erfurth RESTORE Study Group The RESTORE Study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema Ophthalmology 118 2011 615 625
10. Diabetic Retinopathy Clinical Research Network M.J. Elman, L.P. Aiello, R.W. Beck et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema Ophthalmology 117 2010 1064 1077
11. Diabetic Retinopathy Clinical Research Network Writing Committee M.J. Elman, N.M. Bressler, H. Qin et al. Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema Ophthalmology 118 2011 609 614
12. Diabetic Retinopathy Clinical Research Network A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema Ophthalmology 115 2008 1447 1459
13. J. Cunha-Vaz, J.R. Faria de Abreu, A.J. Campos Early breakdown of the blood-retinal barrier in diabetes Br J Ophthalmol 59 1975 649 656
14. T. Qaum, Q. Xu, A.M. Joussen VEGF-initiated blood-retinal barrier breakdown in early diabetes Invest Ophthalmol Vis Sci 42 2001 2408 2413 (Pubitemid 32848873)
15. M.J. Tolentino, J.W. Miller, E.S. Gragoudas Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate Ophthalmology 103 1996 1820 1828 (Pubitemid 26403735)
16. H. Funatsu, H. Yamashita, H. Noma Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema Am J Ophthalmol 133 2002 70 77 (Pubitemid 34076505)
17. N. Ferrara, L. Damico, N. Shams Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration Retina 26 2006 859 870 (Pubitemid 44547437)
18. Q.D. Nguyen, S. Tatlipinar, S.M. Shah Vascular endothelial growth factor is a critical stimulus for diabetic macular edema Am J Ophthalmol 142 2006 961 969
19. Q.D. Nguyen, S.M. Shah, J.S. Heier READ-2 Study Group Primary end point (six months) results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) study Ophthalmology 116 2009 2175 2181
20. Q.D. Nguyen, S.M. Shah, A.A. Khwaja READ-2 Study Group Two-year outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) study Ophthalmology 117 2010 2146 2151
21. D.F. Signorini, O. Leung, R.J. Simes Dynamic balanced randomization for clinical trials Stat Med 12 1993 2343 2350 (Pubitemid 24007153)
22. D.M. Brown, P.A. Campochiaro, R.P. Singh CRUISE Investigators Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study Ophthalmology 117 2010 1124 1133
23. R.W. Beck, M.G. Maguire, N.M. Bressler Visual acuity as an outcome measure in clinical trials of retinal diseases Ophthalmology 114 2007 1804 1809 (Pubitemid 47483941)
24. Antiplatelet Trialists' Collaboration Collaborative overview of randomised trials of antiplatelet therapyI: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients BMJ 308 1994 81 106
25. Early Treatment Diabetic Retinopathy Study Research Group Early photocoagulation for diabetic retinopathy ETDRS report number 9 Ophthalmology 98 suppl 1991 766 785
26. F.E. Hirai, M.D. Knudtson, B.E. Klein, R. Klein Clinically significant macular edema and survival in type 1 and type 2 diabetes Am J Ophthalmol 145 2008 700 706
27. P.A. Campochiaro, D.M. Brown, A. Pearson FAME Study Group Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema Ophthalmology 118 2011 626 635
28. A. Martidis, J.S. Duker, P.B. Greenberg Intravitreal triamcinolone for refractory diabetic macular edema Ophthalmology 109 2002 920 927 (Pubitemid 34465226)
29. Phase 3 study showed MACUGEN improved vision over standard of care in patients with diabetic macular edema [press release] June 5, 2010 Pfizer Inc New York http://media.pfizer.com/files/news/press-releases/2010/pfizer-macugen-dme- 060510.pdf Accessed April 20, 2011
30. M. Michaelides, A. Kaines, R.D. Hamilton A prospective randomized trial of intravitreal Bevacizumab or Laser Therapy in the management of diabetic macular edema (BOLT study): 12-month data: report 2 Ophthalmology 117 2010 1078 1086
31. Diabetic Retinopathy Clinical Research Network A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema Ophthalmology 114 2007 1860 1867
32. P. Bragge, R.L. Gruen, M. Chau Screening for presence or absence of diabetic retinopathy: a meta-analysis Arch Ophthalmol 129 2011 435 444